Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pragmatic Study on the Use of 68Ga-PSMA-617 PET/CT Imaging as a Standard of Care to Influence Clinical Management of Tumors Overexpressing PSMA.

NCT05228106 is registered in ClinicalTrials.gov with Centre de recherche du Centre hospitalier universitaire de Sherbrooke as lead sponsor.

NCT NCT05228106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05228106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pragmatic Study on the Use of 68Ga-PSMA-617 PET/CT Imaging as a Standard of Care to Influence Clinical Management of Tumors Overexpressing PSMA.
Lead sponsor
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Phase
Observational
Overall status
Recruiting
Start date
January 21, 2022
Completion date
January 31, 2027
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid cancers